| Open Targets Platform: new developments and updates two years on D Carvalho-Silva, A Pierleoni, M Pignatelli, CK Ong, L Fumis, ... Nucleic acids research 47 (D1), D1056-D1065, 2019 | 417 | 2019 |
| Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics M Ghoussaini, E Mountjoy, M Carmona, G Peat, EM Schmidt, A Hercules, ... Nucleic acids research 49 (D1), D1311-D1320, 2021 | 318 | 2021 |
| Open Targets Platform: supporting systematic drug–target identification and prioritisation D Ochoa, A Hercules, M Carmona, D Suveges, A Gonzalez-Uriarte, ... Nucleic Acids Research 49 (D1), D1302-D1310, 2021 | 295 | 2021 |
| An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci E Mountjoy, EM Schmidt, M Carmona, J Schwartzentruber, G Peat, ... Nature genetics 53 (11), 1527-1533, 2021 | 229 | 2021 |
| The next-generation Open Targets Platform: reimagined, redesigned, rebuilt D Ochoa, A Hercules, M Carmona, D Suveges, J Baker, C Malangone, ... Nucleic Acids Research 51 (D1), D1353-D1359, 2023 | 105 | 2023 |
| A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance M Anisul, J Shilts, J Schwartzentruber, J Hayhurst, A Buniello, ... Elife 10, e69719, 2021 | 23 | 2021 |
| Open Targets Genetics: An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci E Mountjoy, EM Schmidt, M Carmona, G Peat, A Miranda, L Fumis, ... bioRxiv, 2020 | 14 | 2020 |
| Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins MA Karim, B Ariano, J Schwartzentruber, JM Roldan-Romero, E Mountjoy, ... medRxiv, 2023.06. 01.23290252, 2023 | 1 | 2023 |
Ian DunhamEMBL-EBIVerified email at ebi.ac.uk
